Structure of Chemical Compounds, Methods of Analysis and Process Control Photostability Study in Pharmaceutical Development of a Solid Dosage Form of GML-3, A New Compound with Anxiolytic and Antidepressant Activity

Since the pronounced photosensitivity of the API GML-3, a compound with anxiolytic and antidepressant activity, has been previously shown, the aim of the present study was to select methods for protecting GML-3 in a solid dosage form (tablets) from exposure to light. The effect of electromagnetic ra...

Full description

Saved in:
Bibliographic Details
Published inPharmaceutical chemistry journal Vol. 59; no. 4; pp. 491 - 499
Main Authors Grushevskaya, L. N., Gaevaya, L. M., Markeev, V. B., Sergeeva, M. S., Dorofeev, V. L.
Format Journal Article
LanguageEnglish
Published New York Springer US 01.07.2025
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Since the pronounced photosensitivity of the API GML-3, a compound with anxiolytic and antidepressant activity, has been previously shown, the aim of the present study was to select methods for protecting GML-3 in a solid dosage form (tablets) from exposure to light. The effect of electromagnetic radiation in the near ultraviolet and visible spectral ranges on the stability of GML-3 as part of a dosage form was studied in accordance with regulatory requirements under various conditions, e.g., in a model mixture with excipients, in a tablet mass, and as part of tablet cores and film-coated tablets. It was shown that GML-3 as part of tablets is also subject to photodegradation, but the excipients used in the production of GML-3 tablets do not cause or accelerate this process. Application of Opadry® II 85F18422 film coating made it possible to reduce the degree of GML-3 degradation, but its complete elimination under experimental conditions was achieved only when using primary and secondary packaging in the form of polypropylene jars placed in cardboard packs.
ISSN:0091-150X
1573-9031
DOI:10.1007/s11094-025-03420-1